Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
5,731,001
-
Shares change
-
-231,229
-
Total reported value, excl. options
-
$24,586,557
-
Value change
-
-$1,088,577
-
Put/Call ratio
-
58%
-
Number of buys
-
12
-
Number of sells
-
-20
-
Price
-
$4.29
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q4 2021
45 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q4 2021.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,731,001 shares
of 26,828,643 outstanding shares and own 21.36% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2,385,000 shares), VANGUARD GROUP INC (878,402 shares), AWM Investment Company, Inc. (500,000 shares), Roumell Asset Management, LLC (449,438 shares), BlackRock Inc. (298,643 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (203,263 shares), GEODE CAPITAL MANAGEMENT, LLC (175,853 shares), Westside Investment Management, Inc. (118,525 shares), MARSHALL WACE, LLP (92,092 shares), and PARADIGM CAPITAL MANAGEMENT INC/NY (90,000 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.